Categorized | Journal Articles

Melanoma Journal Articles for November 2017

Science Advances

The abundance of metabolites related to protein methylation correlates with the metastatic capacity of human melanoma xenografts

Xiaolei Shi1, Alpaslan Tasdogan1, Fang Huang1, Zeping Hu1,*, Sean J. Morrison1,2 and Ralph J. DeBerardinis

Science Advances  01 Nov 2017:
Vol. 3, no. 11, eaao5268
DOI: 10.1126/sciadv.aao5268


Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients

Journal of Dermatological Science | November 01, 2017


Australasian Journal of Dermatology

Dermoscopic ‘Chaos and Clues’ in the diagnosis of melanoma in situ

Rajan Ramji, Guillermo Valdes-Gonzalez, Amanda Oakley, Marius Rademaker

First published: 2 November 2017

DOI: 10.1111/ajd.12740


International Journal of Cancer

Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014

Joanne F. Aitken, Danny R. Youlden, Peter D. Baade, H. Peter Soyer, Adèle C. Green, B. Mark Smithers

Accepted manuscript online: 6 November 2017

DOI: 10.1002/ijc.31141


Int. J. Mol. Sci. 201718(11), 2354; doi:10.3390/ijms18112354

miRNAs, Melanoma and Microenvironment: An Intricate Network

Gabriele Romano and Lawrence N. Kwong

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Received: 29 September 2017 / Revised: 2 November 2017 / Accepted: 5 November 2017 / Published: 7 November 2017


BioRxiv

Transcriptional Changes of DNA Replication and Repair Factors Over Uveal Melanoma Subtypes

Melanie H. Kucherlapati

doi: https://doi.org/10.1101/214932


Adverse Reactions to Biologics

Editor(s): Puig L. (Barcelona)
Gulliver W. (St. John’s)

Adverse Reactions to Biologics: Melanoma (Ipilimumab, Nivolumab, Pembrolizumab)

Hwang S.J.E.a, b · Fernández-Peñas P.a, b

Puig L, Gulliver W (eds): Adverse Reactions to Biologics. Curr Probl Dermatol. Basel, Karger, 2018, vol 53, pp 82-92

https://doi.org/10.1159/000478081


The Open Dermatology Journal

ISSN: 1874-3722 – Volume 11, 2017

CASE REPORT

Two-phase Surgery Using a Dermal Regeneration Material for Nail Unit Melanoma: Three Case Reports

Shiro Iino1*, Suguru Sato1, Natsuki Baba1, Naoki Maruta1, Wataru Takashima1, Noritaka Oyama1, Takahiro Kiyohara2, Masato Yasuda3, Minoru Hasegawa1


Dove Press

FGF2 promotes metastasis of uveal melanoma cells via store-operated calcium entry

Authors Wang Y, Bao X, Zhang Z, Sun Y, Zhou X

Received 10 March 2017

Accepted for publication 1 October 2017

Published 8 November 2017 Volume 2017:10 Pages 5317—5328

DOI https://doi.org/10.2147/OTT.S136677


Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases

Maria A. Pizzichetta, Daniela Massi, Mario Mandalà, Paola Queirolo, Ignazio Stanganelli, Vincenzo De Giorgi, Giovanni Ghigliotti, Stefano Cavicchini, Pietro Quaglino, Maria T. Corradin,  Pietro Rubegni, Mauro Alaibac, Stefano Astorino, Fabrizio Ayala, Serena Magi, Laura Mazzoni, Maria Ausilia Manganoni, Renato Talamini, Diego Serraino, Giuseppe Palmieri and on behalf of the Italian Melanoma Intergroup (IMI)

Journal of Translational Medicine 201715:227

https://doi.org/10.1186/s12967-017-1332-3

Received: 24 July 2017

Accepted: 27 October 2017

Published: 7 November 2017


Clinical Cancer Research

Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma

Tuba N. Gide, James S Wilmott, Richard A. Scolyer and Georgina V. Long

DOI: 10.1158/1078-0432.CCR-17-2267


Cell Reports

Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines

Bradley Garman,1,16 Ioannis N. Anastopoulos,1,16 Clemens Krepler,2 Patricia Brafford,2 Katrin Sproesser,2 Yuchao Jiang,3 Bradley Wubbenhorst,1 Ravi Amaravadi,4,5 Joseph Bennett,6 Marilda Beqiri,2 David Elder,5,8 Keith T. Flaherty,9 Dennie T. Frederick,9 Tara C. Gangadhar,4,5 Michael Guarino,6 David Hoon,10 Giorgos Karakousis,11 Qin Liu,2 Nandita Mitra,12 Nicholas J. Petrelli,6 Lynn Schuchter,4,5 Batool Shannan,2 Carol L. Shields,13 Jennifer Wargo,14 Brandon Wenz,1 Melissa A. Wilson,15 Min Xiao,2 Wei Xu,5 Xaiowei Xu,5,8 Xiangfan Yin,2 Nancy R. Zhang,3 Michael A. Davies,7 Meenhard Herlyn,2 and Katherine L. Nathanson

Cell Reports 21, 1936–1952 November 14, 2017. https://doi.org/10.1016/j.celrep.2017.10.052


Clinical Cancer Research

Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690

Mohammed Kashani-Sabet, Mehdi Nosrati, James R. Miller III, Richard W. Sagebiel, Stanley P.L. Leong, Andrew Lesniak, Schuyler Tong, Sandra J. Lee and John M. Kirkwood

DOI: 10.1158/1078-0432.CCR-17-1317 Published November 2017


Spandidos Publications – Oncology Letters

Oridonin inhibits migration, invasion, adhesion and TGF-1-induced epithelial-mesenchymal transition of melanoma cells by inhibiting the activity of PI3K/Akt/GSK-3 signaling pathway

Chun-Yu Li, Qi Wang, Shen Shen, Xiao-Lu Wei, Guo-Xia Li

Published online on: November 15, 2017     https://doi.org/10.3892/ol.2017.7421


Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016

Paolo A. Ascierto, Sanjiv S. Agarwala, Gennaro Ciliberto, Sandra Demaria, Reinhard Dummer, Connie P. M. Duong, Soldano Ferrone, Silvia C. Formenti, Claus Garbe, Ruth Halaban, Samir Khleif, Jason J. Luke, Lluis M. Mir, Willem W. Overwijk, Michael Postow, Igor Puzanov, Paul Sondel, Janis M. Taube, Per Thor Straten, David F. Stroncek, Jennifer A. Wargo, Hassane Zarour and Magdalena Thurin

Journal of Translational Medicine201715:236

https://doi.org/10.1186/s12967-017-1341-2

Received: 1 October 2017

Accepted: 7 November 2017

Published: 16 November 2017


JAMA Oncology

Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma

Andrew J. Sinnamon, MD1Madalyn G. Neuwirth, MD1Phyllis A. Gimotty, PhD2; et alTara C. Gangadhar, MD3Ravi K. Amaravadi, MD3Lynn M. Schuchter, MD3Giorgos C. Karakousis, MD1

Author Affiliations

JAMA Oncol. Published online November 16, 2017.

doi:10.1001/jamaoncol.2017.3462


Histopathology

New insights into naevoid melanomas: a clinicopathological reassessment.

Cook, Martin G, Massi, Daniela, Blokx, Willeke A M, Van den Oord, Joost, Koljenovic, Senada, De Giorgi, Vincenzo, Kissin, Eleanor, Grant, Megan, Mandal, Amit, Gremel, Gabriela, Gaudy, Caroline, Viros, Amaya, Dhomen, Nathalie, Khosrotehrani, Kiarash, Marais, Richard, Green, Adele C and Mihm, Martin C (2017) New insights into naevoid melanomas: a clinicopathological reassessment.. Histopathology, . doi:10.1111/his.13317


High plasma 25-hydroxyvitamin D and high risk of non-melanoma skin cancer: a Mendelian randomisation study of 97849 individuals

U. C. Winsløw, B. G. Nordestgaard, S. Afzal

Accepted manuscript online: 16 November 2017

DOI: 10.1111/bjd.16127


Cancer Research

Interferon-2; signaling in melanocytes and melanoma cells regulates expression of CTLA-4

Xuan Mo, Hanghang Zhang, Sarah Preston, Kayla Martin, Bo Zhou, Nish Vadalia, Ana M Gamero, Jonathan Soboloff, Italo Tempera and M. Raza Zaidi

DOI: 10.1158/0008-5472.CAN-17-1615


Medical Sciences – Cancer and Cancer-Related Research

Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells

Ugo Testa, Germana Castelli and Elvira Pelosi

Received: 16 September 2017 / Revised: 31 October 2017 / Accepted: 8 November 2017 / Published: 20 November 2017

Med. Sci. 20175(4), 28; doi:10.3390/medsci5040028


Oncology Letters

MicroRNA-150 inhibitors enhance cell apoptosis of melanoma by targeting PDCD4

Jianji Wan, Jie Yang, Yueshen Huang, Liehua Deng

Published online on: November 20, 2017     https://doi.org/10.3892/ol.2017.7445


Retrospective multicenter study on results of gamma knife surgery for uveal melanoma in Europe

Author: Mikhail Chernov, Fery Stoica, Gabriela MurgoiRodica StempurszkiDaniela Greto, Selcuk Peker, Meltem Yilmaz, Andrey GolanovValery Kostjuchenko, Olesya Golubeva, Roman Liscak, Gabriela Simonova, Ladislav Novacek, Pavel Ivanov, Irina Zubatkina, Oleg Sinyavskiy, Matthias RadatzThomas Mindermann

Journal: JOURNAL OF RADIOSURGERY AND SBRT 2017


Recruiting former melanoma patients via hospitals in comparison to office-based dermatologists in a register-based cohort study that required indirect contact

  1. R. Zeissig, V. Weyer-Elberich, K. Emrich, H. Binder, S. Fischbeck, B. H. Imruck, P. Friedrich-Mai, M. E. Beuteland M. Blettner

BMC Medical Research Methodology BMC series – open, inclusive and trusted201717:150

https://doi.org/10.1186/s12874-017-0425-2

Received: 19 May 2017

Accepted: 14 November 2017

Published: 22 November 2017


Animal Cells and Systems

B16 melanoma expressing EGFP as a self antigen is differentially immunoedited by tolerogenic thymic epithelial and dendritic cells

Su Gang Kim,Ki Yeon Kim,Seokmann Hong &Moon Gyo Kim

Pages 388-396 | Received 08 Sep 2017, Accepted 08 Nov 2017, Published online: 24 Nov 2017

https://doi.org/10.1080/19768354.2017.1406870


Dermatoscopy of a melanoma less than one millimeter in diameter

Akay, Bengu N., Heper, Aylin Okcu, Clark, Simon, Erdem, Cengizhan, Rosendahl, Cliff O. and Kittler, Harald (2017) International Journal of Dermatology56 12: 1498-1499. doi:10.1111/ijd.13728


Barbara Fontanals-Cirera, Dan Hasson, Chiara Vardabasso, Raffaella Di Micco, Praveen Agrawal, Asif Chowdhury, Madeleine Gantz, Ana de Pablos-Aragoneses, Ari Morgenstern, Pamela Wu, Dan Filipescu, David Valle-Garcia, Farbod Darvishian, Jae-Seok Roe, Michael A. Davies, Christopher R. Vakoc, Eva Hernando, Emily Bernstein.

Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene.

Molecular Cell, 2017; 68 (4): 731 DOI: 10.1016/j.molcel.2017.11.004


PET and SPECT imaging of melanoma: the state of the art

Weijun Wei, Emily B. Ehlerding, Xiaoli Lan, Quanyong Luo, Weibo Cai

Eur J Nucl Med Mol Imaging (2018) 45: 132. https://doi.org/10.1007/s00259-017-3839-5

Review Article  First Online: 30 October 2017


Cancer Research

Vitamin C sensitizes melanoma to BET inhibitors

Gaofeng Wang, Sushmita Mustafi, Vladimir Camarena, Claude-Henry Volmar, Tyler C Huff, David W Sant, Shaun P. Brothers, Zhao-Jun Liu and Claes Wahlestedt

DOI: 10.1158/0008-5472.CAN-17-2040


Cancer Research

New mechanisms of resistance to MEK inhibitors in melanoma revealed by intravital imaging

Hailey E Brighton, Steven P Angus, Tao Bo, Jose Roques, Alicia C Tagliatela, David Darr, Kubra Karagoz, Noah Sciaky, Michael Gatza, Norman E. Sharpless, Gary L. Johnson and James E. Bear

DOI: 10.1158/0008-5472.CAN-17-1653


Ex vivo distribution of gold nanoparticles in choroidal melanoma

Authors Kanavi MR, Asadi S, Ahmadieh H

Received 14 March 2017

Accepted for publication 14 October 2017

Published 30 November 2017 Volume 2017:12 Pages 8527—8529

DOI https://doi.org/10.2147/IJN.S136939


Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts

Jon-Vidar Gaustad, Trude G. Simonsen, Lise Mari K. Andersen and Einar K. Rofstad

Journal of Translational Medicine201715:241

https://doi.org/10.1186/s12967-017-1347-9

Received: 11 August 2017

Accepted: 21 November 2017

Published: 28 November 2017

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories